Table 1.
Materials | Genes | Strategy | Outcomes | Efficacy | Systems | Refs |
---|---|---|---|---|---|---|
FG | GFP, TGF-β1 | encapsulation in FG gel | controlled rAAV-2 delivery for cartilage repair | high efficiency at low FG concentration, decline after 8 days | hMSCs | 50 |
RAD16-I | lacZ, RFP | encapsulation in RAD16-I pure or combined with HA | controlled rAAV-2 delivery for cartilage repair | 80% transduction efficiency with spheres at 0.4%, time-course decline of expression | hMSCs | 51 |
poloxamer F68,poloxamine 908 | lacZ, sox9 | encapsulation in micelles | controlled rAAV-2 delivery for cartilage repair | enhanced expression, restoration in conditions of gene transfer inhibition | hMSCs | 52 |
alginate poloxamer | lacZ, RFP | encapsulation in alginate/poloxamer composite systems | controlled rAAV-2 delivery for cartilage repair | AlgPH155+PF127 [C]) leaded to a most controlled release profile, higher transduction efficiency with AlgPH155+PF127 [H] | hMSCs | 53 |
BMA | lacZ, TGF-β | mixing with rAAV-2 | direct gene transfer of BMA for cartilage repair | enhanced chondrogenesis and reduced hypertrophy with TGF-β | hBMA | 58,61 |
lacZ, TGF-β, sox9, IGF-I | mixing with rAAV-2 | direct gene transfer of BMA for cartilage repair | enhanced chondrogenesis and reduced hypertrophy with sox9 | minipig BMA | 60 | |
lacZ, IGF-I | mixing with rAAV-2 | direct gene transfer of BMA for cartilage repair | enhanced chondrogenesis, hypertrophy, and osteogenesis with IGF-I | hBMA | 59 | |
FG | IGF-I, GFP | rAAV-5-transduced chondrocytes embedded in FG gel | cartilage healing in full-thickness chondral defects | enhanced chondrocyte predominance and type-II collagen expression | chondrocyte implantation in chondral defect (horse) | 63 |
FG/PGA matrix | IGF-I, BMP-2 | rAAV-2-transduced periosteal cells seeded in FG/PGA matrix | cartilage healing in full-thickness chondral defects | enhanced chondrocyte-like morphology with BMP-2 | periosteal cell implantation in chondral defect (minipig) | 65 |
dedifferentiation of cells from superficial zones in contrast to those from deeper zones (chondrocytes morphology) | periosteal cell implantation in chondral defect (minipig) | 64 |
Abbreviations: GFP, green fluorescent protein; TGF-β1, transforming growth factor β 1; lacZ, E. coli β-galactosidase; sox9, sex determining region Y-box 9; RFP, red fluorescent protein; IGF-I, insulin-like growth factor I; BMP-2, bone morphogenetic protein 2; hMSCs, human mesenchymal stem cells; FG, fibrin glue; RAD16-I, (RADA)4 peptide; HA, hyaluronic acid; AlgPH155+PF127 [C], alginate/poloxamer complex systems crosslinked at room temperature; AlgPH155+PF127 [H], alginate/poloxamer complex systems crosslinked at high temperature (50°C); hBMA, human bone marrow aspirates; PGA, poly(glycolic acid).